Insulin resistance is a leading cause of cardiomyopathies by reduced GLUT4 translocation, free fatty acid deposition, and cardiac impairment via altered PI3K-Akt-GLUT4 signaling pathways [164]. Here, SLC2A4 is linked to Insulin resistance.